These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

450 related articles for article (PubMed ID: 17261530)

  • 21. The role of TLR4 in pathophysiology of antiphospholipid syndrome-associated thrombosis and pregnancy morbidity.
    Xie H; Sheng L; Zhou H; Yan J
    Br J Haematol; 2014 Jan; 164(2):165-76. PubMed ID: 24180619
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Complement C5-inhibitor rEV576 (coversin) ameliorates in-vivo effects of antiphospholipid antibodies.
    Romay-Penabad Z; Carrera Marin AL; Willis R; Weston-Davies W; Machin S; Cohen H; Brasier A; Gonzalez EB
    Lupus; 2014 Oct; 23(12):1324-6. PubMed ID: 25228739
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Pathogenic mechanisms of the anti-phospholipid antibodies].
    Núñez-Álvarez CA; Cabiedes J
    Reumatol Clin; 2011; 7(1):72-6. PubMed ID: 21794784
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Activated protein C resistance and lupus anticoagulant activity induced by plasma and purified monospecific human IgG anti-beta2-glycoprotein-I antibodies.
    Viveros ME; Cabiedes J; Reyes E; Cabral AR
    Rev Invest Clin; 2005; 57(4):563-71. PubMed ID: 16315641
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The involvement of CD36 in monocyte activation by antiphospholipid antibodies.
    Kato M; Atsumi T; Oku K; Amengual O; Nakagawa H; Fujieda Y; Otomo K; Horita T; Yasuda S; Koike T
    Lupus; 2013 Jul; 22(8):761-71. PubMed ID: 23817509
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of human IgG antiphospholipid antibodies on an in vivo thrombosis model in mice.
    Pierangeli SS; Barker JH; Stikovac D; Ackerman D; Anderson G; Barquinero J; Acland R; Harris EN
    Thromb Haemost; 1994 May; 71(5):670-4. PubMed ID: 8091396
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antiphospholipid syndrome: critical analysis of the diagnostic path.
    Pengo V; Banzato A; Bison E; Denas G; Padayattil Jose S; Ruffatti A
    Lupus; 2010 Apr; 19(4):428-31. PubMed ID: 20353982
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Proteomic analysis in monocytes of antiphospholipid syndrome patients: deregulation of proteins related to the development of thrombosis.
    López-Pedrera C; Cuadrado MJ; Herández V; Buendïa P; Aguirre MA; Barbarroja N; Torres LA; Villalba JM; Velasco F; Khamashta M
    Arthritis Rheum; 2008 Sep; 58(9):2835-44. PubMed ID: 18759277
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Novel considerations in the pathogenesis of the antiphospholipid syndrome: involvement of the tissue factor pathway of blood coagulation.
    Adams M
    Semin Thromb Hemost; 2008 Apr; 34(3):251-5. PubMed ID: 18720304
    [TBL] [Abstract][Full Text] [Related]  

  • 30. C5a receptor-deficient mice are protected from thrombophilia and endothelial cell activation induced by some antiphospholipid antibodies.
    Romay-Penabad Z; Liu XX; Montiel-Manzano G; Papalardo De Martínez E; Pierangeli SS
    Ann N Y Acad Sci; 2007 Jun; 1108():554-66. PubMed ID: 17894020
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antiphospholipid antibodies and thrombosis: association with acquired activated protein C resistance in venous thrombosis and with hyperhomocysteinemia in arterial thrombosis.
    Kassis J; Neville C; Rauch J; Busque L; Chang ER; Joseph L; Le Comte M; Subang R; Fortin PR
    Thromb Haemost; 2004 Dec; 92(6):1312-9. PubMed ID: 15583739
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anti-heparin platelet factor 4 antibodies in systemic lupus erythematosus are associated with IgM antiphospholipid antibodies and the antiphospholipid syndrome.
    Alpert D; Mandl LA; Erkan D; Yin W; Peerschke EI; Salmon JE
    Ann Rheum Dis; 2008 Mar; 67(3):395-401. PubMed ID: 17644539
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A peptide that mimics the Vth region of beta-2-glycoprotein I reverses antiphospholipid-mediated thrombosis in mice.
    Ostertag MV; Liu X; Henderson V; Pierangeli SS
    Lupus; 2006; 15(6):358-65. PubMed ID: 16830882
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of an Fc gamma receptor-independent mechanism by which intravenous immunoglobulin ameliorates antiphospholipid antibody-induced thrombogenic phenotype.
    Pierangeli SS; Espinola R; Liu X; Harris EN; Salmon JE
    Arthritis Rheum; 2001 Apr; 44(4):876-83. PubMed ID: 11315927
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevalence of antibodies to beta2-glycoprotein I in systemic lupus erythematosus and their association with antiphospholipid antibody syndrome criteria: a single center study and literature review.
    Bruce IN; Clark-Soloninka CA; Spitzer KA; Gladman DD; Urowitz MB; Laskin CA
    J Rheumatol; 2000 Dec; 27(12):2833-7. PubMed ID: 11128672
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antiphospholipid syndrome nephropathy in patients with systemic lupus erythematosus and antiphospholipid antibodies: prevalence, clinical associations, and long-term outcome.
    Tektonidou MG; Sotsiou F; Nakopoulou L; Vlachoyiannopoulos PG; Moutsopoulos HM
    Arthritis Rheum; 2004 Aug; 50(8):2569-79. PubMed ID: 15334471
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Determinants of risk for venous and arterial thrombosis in primary antiphospholipid syndrome and in antiphospholipid syndrome with systemic lupus erythematosus.
    Danowski A; de Azevedo MN; de Souza Papi JA; Petri M
    J Rheumatol; 2009 Jun; 36(6):1195-9. PubMed ID: 19447935
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Autoantibody explosion in antiphospholipid syndrome.
    Shoenfeld Y; Twig G; Katz U; Sherer Y
    J Autoimmun; 2008; 30(1-2):74-83. PubMed ID: 18171610
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anti-beta2-glycoprotein I antibodies in pediatric systemic lupus erythematosus and antiphospholipid syndrome.
    von Scheven E; Glidden DV; Elder ME
    Arthritis Rheum; 2002 Aug; 47(4):414-20. PubMed ID: 12209489
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The dual role of innate immunity in the antiphospholipid syndrome.
    Rauch J; Dieudé M; Subang R; Levine JS
    Lupus; 2010 Apr; 19(4):347-53. PubMed ID: 20353968
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.